Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study

OBJECTIVES: The aim was to evaluate the safety and effectiveness of thalidomide, an immunomodulatory agent, in combination with glucocorticoid, for the treatment of COVID-19 patients with life-threatening symptoms. METHODS: A nonrandomized comparative case series study was performed. Six patients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuping, Shi, Keqing, Qi, Feng, Yu, Zhijie, Chen, Chengshui, Pan, Jingye, Wu, Gaojun, Chen, Yanfang, Li, Ji, Chen, Yongping, Zhou, Tieli, Li, Xiaokun, Xia, Jinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834521/
https://www.ncbi.nlm.nih.gov/pubmed/33333254
http://dx.doi.org/10.1016/j.ijid.2020.12.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834521/
https://www.ncbi.nlm.nih.gov/pubmed/33333254
http://dx.doi.org/10.1016/j.ijid.2020.12.023

Ejemplares similares